G01N 2333/445
Plasmodium
G01N2333/445 (Plasmodium) appears on 115 US grants and 170 published applications in this corpus.
Search patents in G01N- Granted patents
- 115
- Published applications
- 170
- Assignees
- 106
- Inventors
- 445
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 2 | 5 |
| 2005 | 1 | 2 |
| 2006 | 1 | 7 |
| 2007 | 2 | 6 |
| 2008 | 1 | 1 |
| 2009 | 6 | 9 |
| 2010 | 0 | 15 |
| 2011 | 4 | 16 |
| 2012 | 8 | 4 |
| 2013 | 10 | 9 |
| 2014 | 8 | 10 |
| 2015 | 7 | 7 |
| 2016 | 7 | 10 |
| 2017 | 7 | 14 |
| 2018 | 5 | 9 |
| 2019 | 9 | 6 |
| 2020 | 6 | 10 |
| 2021 | 5 | 8 |
| 2022 | 3 | 5 |
| 2023 | 5 | 2 |
| 2024 | 4 | 5 |
| 2025 | 6 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Spectral imaging platform for infectious disease diagnosis18 Nov 2025US 12,474,344 B2The Board of Trustees of the Leland Stanford Junior University
- Preventing and treating malaria7 Oct 2025US 12,433,869 B2
- Malaria species detection29 Jul 2025US 12,372,512 B2Hemex Health, Inc.
- Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use8 Apr 2025US 12,269,872 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- System, method, apparatus and diagnostic test for plasmodium vivax25 Mar 2025US 12,259,387 B2The Walter and Eliza Hall Institute of Medical Research
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Anti-csp antibody variants6 Aug 2026US 2026/0226147 A1Atreca, Inc.
- Recombinant var2csa protein, and preparation method and use thereof16 Jul 2026US 2026/0200996 A1Sun Yat-sen University Cancer Center (The Affiliated Cancer Hospital of Sun Yat-sen University, The
- Preventing and treating malaria25 Dec 2025US 2025/0387368 A1
- Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use21 Aug 2025US 2025/0263478 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Assay implementation in a microfluidic format74US 7,553,453 B2Honeywell International Inc. · 2009
- Histone deacetylase as target for antiprotozoal agents47US 6,068,987 AMerck & Co., Inc. · 2000
- Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays31US 5,532,133 ANew York University · 1996
- Histone deacetylase as target for antiprotozoal agents29US 6,110,697 AMerck & Co., Inc. · 2000
- Therapeutic target for protozoal diseases26US 7,438,916 B2Virginia Tech Intellectual Properties, Inc. · 2008